In this interview, Thermo Fisher Scientific discusses how to accelerate drug discovery through analytical R&D.
Exclusive: BioNTech acquires lipid nanoparticle startup founded by George Mason and UPenn scientists
BioNTech, the German drug company famous for developing a Covid-19 vaccine with Pfizer, has acquired AexeRNA and its novel lipid nanoparticles for mRNA medicines, Endpoints